Brian Van Tine, MD @bvantine1 @WUSTLmed @WUSTL @Adaptimmune #ASCO21 #SPEARHEAD1 #Sarcoma #Cancer #Research SPEARHEAD-1 A Phase 2 Trial Editor 3 years ago